“
TL;DR
This preclinical study in mice showed that restoring normal blood flow by removing an atherosclerosis-inducing cuff led to plaque stabilization, a benefit comparable to the drug atorvastatin.
iScience · 10 authors, 6 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This preclinical study in mice showed that restoring normal blood flow by removing an atherosclerosis-inducing cuff led to plaque stabilization, a benefit comparable to the drug atorvastatin.
The cuff was then either maintained or removed to restore normal blood flow for a four-week therapeutic period. The therapeutic benefit of restoring normal blood flow was comparable to treatment with atorvastatin, and the combination had an additive effect.